Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Risk adjusted net present value: What is the current valuation of Disc Medicine's DISC-0974?
DISC-0974 is a monoclonal antibody commercialized by Disc Medicine, with a leading Phase II program in Chronic Idiopathic Myelofibrosis (Primary...
DISC-0974 by Disc Medicine for Anemia in Chronic Kidney Disease (Renal Anemia): Likelihood of Approval
DISC-0974 is under clinical development by Disc Medicine and currently in Phase II for Anemia in Chronic Kidney Disease (Renal...
DISC-0974 by Disc Medicine for Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis): Likelihood of Approval
DISC-0974 is under clinical development by Disc Medicine and currently in Phase II for Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis). According...
Risk adjusted net present value: What is the current valuation of Disc Medicine's DISC-0974?
DISC-0974 is a monoclonal antibody commercialized by Disc Medicine, with a leading Phase II program in Anemia in Chronic Kidney...